241 related articles for article (PubMed ID: 15916986)
41. Reduced isoflavone metabolites formed by the human gut microflora suppress growth but do not affect DNA integrity of human prostate cancer cells.
Raschke M; Wähälä K; Pool-Zobel BL
Br J Nutr; 2006 Sep; 96(3):426-34. PubMed ID: 16925846
[TBL] [Abstract][Full Text] [Related]
42. A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence.
Jacobs EJ; Rodriguez C; Mondul AM; Connell CJ; Henley SJ; Calle EE; Thun MJ
J Natl Cancer Inst; 2005 Jul; 97(13):975-80. PubMed ID: 15998950
[TBL] [Abstract][Full Text] [Related]
43. Development of a database for assessing dietary phytoestrogen intake.
Pillow PC; Duphorne CM; Chang S; Contois JH; Strom SS; Spitz MR; Hursting SD
Nutr Cancer; 1999; 33(1):3-19. PubMed ID: 10227038
[TBL] [Abstract][Full Text] [Related]
44. Phytoestrogens and cardiovascular disease.
Cassidy A; Hooper L
J Br Menopause Soc; 2006 Jun; 12(2):49-56. PubMed ID: 16776855
[TBL] [Abstract][Full Text] [Related]
45. [Complementary medicine: phytotherapy and soyaisoflavones as phytoestrogens].
Melzer J; Brignoli R; Saller R
Zentralbl Gynakol; 2004 Jun; 126(3):138-47. PubMed ID: 15236098
[TBL] [Abstract][Full Text] [Related]
46. Selenium, genetic variation, and prostate cancer risk: epidemiology reflects back on selenium and vitamin E cancer prevention trial.
Platz EA; Lippman SM
J Clin Oncol; 2009 Aug; 27(22):3569-72. PubMed ID: 19528369
[No Abstract] [Full Text] [Related]
47. Phytoestrogens as cardioprotective agents.
Park D; Huang T; Frishman WH
Cardiol Rev; 2005; 13(1):13-7. PubMed ID: 15596022
[TBL] [Abstract][Full Text] [Related]
48. CYP1A1 polymorphisms and risk of prostate cancer: a meta-analysis.
Shaik AP; Jamil K; Das P
Urol J; 2009; 6(2):78-86. PubMed ID: 19472123
[TBL] [Abstract][Full Text] [Related]
49. Dietary phytoestrogens and health.
Cornwell T; Cohick W; Raskin I
Phytochemistry; 2004 Apr; 65(8):995-1016. PubMed ID: 15110680
[TBL] [Abstract][Full Text] [Related]
50. Dietary phytoestrogens and lung cancer risk.
Schabath MB; Hernandez LM; Wu X; Pillow PC; Spitz MR
JAMA; 2005 Sep; 294(12):1493-504. PubMed ID: 16189362
[TBL] [Abstract][Full Text] [Related]
51. [Use of phytoestrogens in medicine].
Tutel'ian VA; Pavliuchkova MS; Pogozheva AV; Derbeneva SA
Vopr Pitan; 2003; 72(2):48-54. PubMed ID: 12924211
[TBL] [Abstract][Full Text] [Related]
52. Breast, colorectal, and prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition-Norfolk in relation to phytoestrogen intake derived from an improved database.
Ward HA; Kuhnle GG; Mulligan AA; Lentjes MA; Luben RN; Khaw KT
Am J Clin Nutr; 2010 Feb; 91(2):440-8. PubMed ID: 20007303
[TBL] [Abstract][Full Text] [Related]
53. Role of mammalian lignans in the prevention and treatment of prostate cancer.
McCann MJ; Gill CI; McGlynn H; Rowland IR
Nutr Cancer; 2005; 52(1):1-14. PubMed ID: 16090998
[TBL] [Abstract][Full Text] [Related]
54. Soy isoflavone phyto-pharmaceuticals in interleukin-6 affections. Multi-purpose nutraceuticals at the crossroad of hormone replacement, anti-cancer and anti-inflammatory therapy.
Dijsselbloem N; Vanden Berghe W; De Naeyer A; Haegeman G
Biochem Pharmacol; 2004 Sep; 68(6):1171-85. PubMed ID: 15313415
[TBL] [Abstract][Full Text] [Related]
55. Nutrition, dietary supplements and adenocarcinoma of the prostate.
Schultz C; Meier M; Schmid HP
Maturitas; 2011 Dec; 70(4):339-42. PubMed ID: 22001108
[TBL] [Abstract][Full Text] [Related]
56. Enterolactone and breast cancer: methodological issues may contribute to conflicting results in observational studies.
Sonestedt E; Wirfält E
Nutr Res; 2010 Oct; 30(10):667-77. PubMed ID: 21056282
[TBL] [Abstract][Full Text] [Related]
57. Lack of prospective associations between plasma and urinary phytoestrogens and risk of prostate or colorectal cancer in the European Prospective into Cancer-Norfolk study.
Ward H; Chapelais G; Kuhnle GG; Luben R; Khaw KT; Bingham S
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2891-4. PubMed ID: 18843034
[TBL] [Abstract][Full Text] [Related]
58. Dietary phytoestrogens and biomarkers of their intake in relation to cancer survival and recurrence: a comprehensive systematic review with meta-analysis.
Micek A; Godos J; Brzostek T; Gniadek A; Favari C; Mena P; Libra M; Del Rio D; Galvano F; Grosso G
Nutr Rev; 2021 Jan; 79(1):42-65. PubMed ID: 32632445
[TBL] [Abstract][Full Text] [Related]
59. Phytoestrogens and breast cancer.
Adlercreutz H
J Steroid Biochem Mol Biol; 2002 Dec; 83(1-5):113-8. PubMed ID: 12650707
[TBL] [Abstract][Full Text] [Related]
60. Phytoestrogens and risk of prostate cancer: an updated meta-analysis of epidemiologic studies.
Zhang Q; Feng H; Qluwakemi B; Wang J; Yao S; Cheng G; Xu H; Qiu H; Zhu L; Yuan M
Int J Food Sci Nutr; 2017 Feb; 68(1):28-42. PubMed ID: 27687296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
